Sagent Pharmaceuticals Announces FDA Approval Of Labetalol Hydrochloride Injection, USP
Links shared publicly online about this topic.
- 1,394total visits
Sagent Pharmaceuticals Announces FDA Approval Of Labetalol Hydrochloride Injection, USP
Sagent Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, announced that it has received FDA approval of labetalol hydrochloride (HCl) injection, USP, commonly used to contr
View full resource at medicalnewstoday.com
Tags: Pharma, FDA, Beta Blocker, Normodyne, Trandate
Most Recently Shared on February 9, 2010 at 6:15 pm By:
Sagent Pharmaceuticals Announces FDA Approval Of Labetalol Hydrochloride Injection, USP http://mnt.to/3xnF #clinicaltrials
Advertisement
